T h e ne w e ngl a nd jou r na l o f m e dic i ne A 62-year-old man presents with a three-day history of progressive dyspnea, nonproductive cough, and low-grade fever. He had been hospitalized two years earlier for congestive heart failure. His blood pressure is 95/55 mm Hg, his heart rate 110 beats per minute, his temperature 37.9°C, and his oxygen saturation while breathing ambient air 86 percent. Chest auscultation reveals rales and rhonchi bilaterally. A chest radiograph shows bilateral pulmonary infiltrates consistent with pulmonary edema and borderline enlargement of the cardiac silhouette. How should this patient be evaluated to establish the cause of the acute pulmonary edema and to determine appropriate therapy?
lung microcirculation is approximately equal to the hydrostatic pressure in the pulmonary capillaries (Fig. 1A) , which is partially offset by a protein osmotic pressure gradient.
A rapid increase in hydrostatic pressure in the pulmonary capillaries leading to increased transvascular fluid filtration is the hallmark of acute cardiogenic or volume-overload edema (Fig. 1B) . Increased hydrostatic pressure in the pulmonary capillaries is usually due to elevated pulmonary venous pressure from increased left ventricular end-diastolic pressure and left atrial pressure. Mild elevations of left atrial pressure (18 to 25 mm Hg) cause edema in the perimicrovascular and peribronchovascular interstitial spaces. 7 As left atrial pressure rises further (>25 mm Hg), edema fluid breaks through the lung epithelium, flooding the alveoli with protein-poor fluid 7 (Fig. 1B) .
By contrast, noncardiogenic pulmonary edema is caused by an increase in the vascular permeability of the lung, resulting in an increased flux of fluid and protein into the lung interstitium and air spaces (Fig. 1C) . Noncardiogenic pulmonary edema has a high protein content because the vascular membrane is more permeable to the outward movement of plasma proteins. The net quantity of accumulated pulmonary edema is determined by the balance between the rate at which fluid is filtered into the lung 7 and the rate at which fluid is removed from the air spaces and lung interstitium. 6 strategies and evidence evaluation
History and Physical Examination
The presenting features of acute cardiogenic and noncardiogenic pulmonary edema are similar. Interstitial edema causes dyspnea and tachypnea. Alveolar flooding leads to arterial hypoxemia and may be associated with cough and expectoration of frothy edema fluid. The history should focus on determining the underlying clinical disorder that has led to pulmonary edema. 8 Common causes of cardiogenic pulmonary edema include ischemia with or without myocardial infarction, exacerbation of chronic systolic or diastolic heart failure, and dysfunction of the mitral or aortic valve. Volume overload should also be considered. A typical history of paroxysmal nocturnal dyspnea or orthopnea suggests cardiogenic pulmonary edema. However, a silent myocardial infarction or occult diastolic dysfunction may also manifest as acute pulmonary edema, with few clues provided by the history. 9 In contrast, noncardiogenic pulmonary edema is associated primarily with other clinical disorders, including pneumonia, sepsis, aspiration of gastric contents, and major trauma associated with the administration of multiple blood-product transfusions. 3 The history should focus on signs and symptoms of infection, a decrease in the level of consciousness associated with vomiting, trauma, and details of medications and ingestions. Unfortunately, the history is not always reliable in distinguishing cardiogenic from noncardiogenic pulmonary edema. For example, an acute myocardial infarction (suggesting cardiogenic edema) may be complicated by syncope or cardiac arrest with aspiration of gastric contents and noncardiogenic edema. Conversely, in patients with severe trauma or infection (suggesting noncardiogenic edema), fluid resuscitation may lead to volume overload and pulmonary edema from an increase in lung vascular hydrostatic pressure.
Patients with cardiogenic pulmonary edema often have an abnormal cardiac examination. Auscultation of an S 3 gallop is relatively specific for elevated left ventricular end-diastolic pressure and left ventricular dysfunction 10-13 and suggests cardiogenic pulmonary edema. [10] [11] [12] The specificity of this finding is high (90 to 97 percent), but its sensitivity is low (9 to 51 percent). 10-13 The wide range of sensitivity probably reflects the difficulty in clearly identifying an S 3 gallop on physical examination, a particular challenge in a critically ill patient in whom intrathoracic sounds created by mechanical ventilation interfere with auscultation.
Data are lacking on the sensitivity and specificity of other findings on examination for cardiogenic edema. A murmur consistent with valvular stenosis or regurgitation should raise suspicion for the diagnosis of cardiogenic edema. Elevated neck veins, an enlarged and tender liver, and peripheral edema suggest elevated central venous pressure. However, assessment of central venous pressure by physical examination in a critically ill patient can be difficult. Also, peripheral edema is not specific for left heart failure and may be associated with hepatic or renal insufficiency, right heart failure, or systemic infection. The lung examination is not helpful, since alveolar flooding from any cause will manifest as inspiratory crackles and often rhonchi. The abdominal, pelvic, and rectal examinations are important. An intraabdominal crisis such as perforation of a viscus can cause acute lung injury with noncardiogenic edema, and patients who are mechanically ventilated may be unable to provide a history of abdominal symptoms. Patients with noncardiogenic edema often have warm extremities, even in the absence of sepsis, whereas patients with cardiogenic edema and poor cardiac output usually have cool extremities.
Laboratory Testing
Electrocardiographic findings may suggest myocardial ischemia or infarction. Elevated troponin levels may indicate damage to myocytes. However, elevated troponin levels can occur in patients with severe sepsis in the absence of evidence for an acute coronary syndrome. 14-17 In a patient who is obtunded and has pulmonary edema of an unknown cause, measurement of electrolytes, the serum osmolarity, and a toxicology screen may lead to the diagnosis of an unsuspected ingestion. Elevated levels of serum amylase and lipase suggest acute pancreatitis.
Plasma levels of brain natriuretic peptide (BNP) are often used in the evaluation of pulmonary edema. BNP is secreted predominantly by the cardiac ventricles in response to wall stretch or increased intracardiac pressures. In patients with congestive heart failure, plasma BNP levels correlate with left ventricular end-diastolic pressure 18-21 and pulmonary-artery occlusion pressure. 22 According to a consensus panel, a BNP level below 100 pg per milliliter indicates that heart failure is unlikely (negative predictive value, >90 percent), whereas a BNP level greater than 500 pg per milliliter indicates that heart failure is likely (positive predictive value, >90 percent). 23 However, BNP levels between 100 and 500 pg per milliliter provide inadequate diagnostic discrimination.
BNP levels must be interpreted with caution in critically ill patients, since the predictive value of BNP levels is uncertain in this group. Some reports indicate that BNP levels can be elevated in critically ill patients even in the absence of heart failure. 24,25 Levels between 100 and 500 pg per milliliter are common in these patients. 26 In one report, all eight patients with sepsis with normal left ventricular function had BNP levels above 500 pg per milliliter. 27 Thus, measuring BNP is most useful in critically ill patients if the level is below 100 pg per milliliter. BNP levels are also higher in patients with renal failure independent of heart failure, and a cutoff of below 200 pg per milliliter has been suggested to exclude heart failure when the estimated glomerular filtration rate is below 60 ml per minute. 23 BNP can also be secreted by , where Q is the net transvascular flow of fluid, K is the membrane permeability, Pmv is the hydrostatic pressure in the microvessels, Ppmv is the hydrostatic pressure in the perimicrovascular interstitium, πmv is the plasma protein osmotic pressure in the circulation, and πpmv is the protein osmotic pressure in the perimicrovascular interstitium. When hydrostatic pressure increases in the microcirculation, the rate of transvascular fluid filtration rises (Panel B). When lung interstitial pressure exceeds pleural pressure, fluid moves across the visceral pleura, creating pleural effusions. Since the permeability of the capillary endothelium remains normal, the filtered edema fluid leaving the circulation has a low protein content. The removal of edema fluid from the air spaces of the lung depends on active transport of sodium and chloride across the alveolar epithelial barrier. The primary sites of sodium and chloride reabsorption are the epithelial ion channels located on the apical membrane of alveolar epithelial type I and II cells and distal airway epithelia. Sodium is actively extruded into the interstitial space by means of the Na + /K + -ATPase located on the basolateral membrane of type II cells. Water follows passively, probably through aquaporins, which are water channels that are found predominantly on alveolar epithelial type I cells.
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Noncardiogenic pulmonary edema (Panel C) occurs when the permeability of the microvascular membrane increases because of direct or indirect lung injury (including the acute respiratory distress syndrome), resulting in a marked increase in the amount of fluid and protein leaving the vascular space. Noncardiogenic pulmonary edema has a high protein content because the more permeable microvascular membrane has a reduced capacity to restrict the outward movement of larger molecules such as plasma proteins. The degree of alveolar flooding depends on the extent of interstitial edema, the presence or absence of injury to the alveolar epithelium, and the capacity of the alveolar epithelium to actively remove alveolar edema fluid. In edema due to acute lung injury, alveolar epithelial injury commonly causes a decrease in the capacity for the removal of alveolar fluid, delaying the resolution of pulmonary edema.
the right ventricle, and moderate elevations have been reported in patients with acute pulmonary embolism, cor pulmonale, and pulmonary hypertension. 23 
Chest Radiography
The distinct mechanisms of cardiogenic and noncardiogenic pulmonary edema result in some moderately distinguishing findings on a posteroanterior or portable anteroposterior chest radiograph 28-30 (Fig. 2) . In a study of 45 patients with pulmonary edema in whom the cause was determined clinically and with the use of sampling of pulmonary edema fluid, 31 a composite score based on the radiographic features in Table 1 correctly identified 87 percent of the patients who had cardiogenic edema and 60 percent of those who had noncardiogenic edema. A measurement of the width of the vascular pedicle may improve the diagnostic accuracy of the chest radiograph, but its utility in distinguishing cardiogenic from noncardiogenic edema needs further evaluation. 32 There are several explanations for the limited diagnostic accuracy of the chest radiograph. Edema may not be visible until the amount of lung water increases by 30 percent. 33 Also, any radiolucent material that fills the air spaces (such as alveolar hemorrhage, pus, and bronchoalveolar carcinoma) will produce a radiographic image similar to that of pulmonary edema. Technical issues can also reduce the sensitivity and specificity of the chest radiograph, including rotation, inspiration, positive-pressure ventilation, position of the patient, and underpenetration or overpenetration of the film. There is also substantial interobserver variability in the interpretation of radiographs. 34, 35 Echocardiography Bedside transthoracic echocardiography can evaluate myocardial and valvular function and can help identify the cause of pulmonary edema. 36 Among 49 critically ill patients with unexplained pulmonary edema or hypotension, evaluation of left ventricular function with the use of two-dimensional transthoracic echocardiography and data generated from a pulmonary-artery catheter were in agreement in 86 percent of patients. 37 These data, combined with other data from critically ill patients, 38 suggest that transthoracic echocardiography should be the first approach to assessing left ventricular and valvular function in patients in whom the history, physical and laboratory ex- Panel A shows an anteroposterior chest radiograph from a 51-year-old man who presented with acute anterior myocardial infarction and acute cardiogenic pulmonary edema. Note the enlargement of the peribronchovascular spaces (arrowheads) and the prominent septal lines (Kerley's B lines) (arrows) as well as acinar areas of increased opacity that coalesce into frank consolidations. The periphery is relatively spared, a common finding in cardiogenic edema.
31 Panel B shows an anteroposterior chest radiograph from a 22-year-old woman whose blood culture was positive for Streptococcus pneumoniae, causing pneumonia complicated by septic shock and acute respiratory distress syndrome. Diffuse alveolar infiltrates appear patchy and bilateral with air bronchograms (arrows), findings that are characteristic of, but not specific for, noncardiogenic edema and acute lung injury.
31 Although involved, the left upper lobe is relatively spared. There is no evidence of vascular engorgement or redistribution of pulmonary blood flow.
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aminations, and the chest radiograph do not establish the cause of pulmonary edema. In some critically ill patients the transthoracic echocardiogram may not be sufficiently informative. 39 Alternatively, transesophageal echocardiography may be useful, 40 with rates of adverse events such as oropharyngeal bleeding, hypotension related to sedation, arrhythmias, and dislodgment of feeding tubes reported to be 1 percent to 5 percent in critically ill patients. 41 Although echocardiography is effective in identifying left ventricular systolic dysfunction and valvular dysfunction, it is less sensitive in identifying diastolic dysfunction. 42 Thus, a normal echocardiogram by standard methods does not rule out cardiogenic pulmonary edema. Newer echocardiographic techniques such as tissue Doppler imaging of the mitral-valve annulus may be used to determine left ventricular end-diastolic pressure and to assess diastolic dysfunction. 43
Pulmonary-Artery Catheterization
Pulmonary-artery catheterization, used to assess the pulmonary-artery occlusion pressure, is considered the gold standard for determining the cause of acute pulmonary edema. 44 Pulmonary-artery catheterization also permits monitoring of cardiac filling pressures, cardiac output, and systemic vascular resistance during treatment.
A pulmonary-artery occlusion pressure above 18 mm Hg indicates cardiogenic pulmonary edema or pulmonary edema due to volume overload.
In two recent, large, randomized trials of pulmonary-artery catheterization for the management of heart failure or critical illness, the rate of adverse advents was 4.5 to 9.5 percent. 45, 46 Common complications included hematoma at the insertion site, arterial puncture, bleeding, arrhythmias, and bloodstream infection; there were no fatalities. Measurement of central venous pressure should not be considered a valid substitute for pulmonary-artery catheterization, since available data suggest that there is often a poor correlation between the two. 44 Elevated central venous pressure may reflect acute or chronic pulmonary arterial hypertension and right ventricular overload in the absence of any increase in left atrial pressure.
stepwise approach
Our algorithm for the diagnostic approach to the patient with pulmonary edema (Fig. 3) has not been validated but instead is based on our clinical experience and on data regarding the value of various clinical and laboratory findings for distinguishing the cause of pulmonary edema. Because the noninvasive approaches for diagnosis will inevitably lead to the misclassification of some patients, repeated and ongoing assessment is necessary. Although the presentation of the algorithm is stepwise, providing care to the critically ill patient is a dynamic process, often requiring simultaneous diagnosis and treatment. Thus, some treatments (such as diuretic therapy for suspected cardiogenic edema, in the absence of a contrain- 31 † The width of the vascular pedicle is determined by dropping a perpendicular line from the point at which the left subclavian artery exits the aortic arch and measuring across to the point at which the superior vena cava crosses the right mainstem bronchus. A vascular-pedicle width greater than 70 mm on a portable digital anteroposterior radiograph of the chest when the patient is supine is optimal for differentiating high from normal-to-low intravascular volume. dication) may be initiated empirically before testing (e.g., echocardiography) takes place. In addition, perhaps 10 percent of patients with acute pulmonary edema have multiple causes of edema. 47, 48 For example, a patient with septic shock and acute lung injury may have volume overload due to aggressive fluid resuscitation or myocardial dysfunction, and a patient with acute exacerbation of congestive heart failure may have pneumonia and associated acute lung injury. 49 In patients with an uncertain cause or possible multiple causes of edema, insertion of a pulmonaryartery catheter may be necessary.
areas of uncertainty
We know of no prospective clinical studies that have assessed the relative contribution of the diagnostic methods currently in use for determining the cause of pulmonary edema. In one study that compared pulmonary-artery catheterization with clinical assessment by physicians, catheterization was superior for determining the cause of acute pulmonary edema. 50 However, that study predated the routine use of BNP and echocardiography, both of which are likely to increase the sensitivity and specificity of the noninvasive determination of the cause of pulmonary edema.
guidelines
There are currently no published guidelines from professional societies for the differentiation between cardiogenic and noncardiogenic pulmonary edema.
conclusions and recommendations
For patients presenting with acute pulmonary edema, such as the one described in the vignette, evaluation should begin with a careful history and physical examination. Special attention should be paid to signs and symptoms of acute or chronic cardiac disease, as well as evidence for a primary pulmonary process such as pneumonia or a nonpulmonary source of infection such as peritonitis. An electrocardiogram should be obtained to rule out ischemic changes, although such changes alone would not establish that the pulmonary edema was cardiogenic. Measurement of plasma BNP is warranted and is most useful if the value is below 100 pg per milliliter, a level at which congestive heart failure is unlikely. The chest radiograph should be reviewed with attention to features suggesting cardiogenic edema (e.g., increased heart size and central distribution of edema) as opposed to noncardiogenic edema. If the diagnosis remains uncertain, a transthoracic echocardiogram can evaluate left ventricular systolic function and aortic-and mitral-valve function.
With the use of the stepwise approach in the diagnostic algorithm, the majority of patients with acute pulmonary edema will be diagnosed noninvasively, and treatment can be provided while the diagnostic steps are taken. For example, if infection is suspected, antibiotic therapy should be initiated after obtaining appropriate cultures. Similarly, if the patient requires mechanical ventilation, and there is uncertainty about the cause of the pulmonary edema, then a lung-protective strategy of ventilation with a low tidal volume is recommended. In some patients, particularly those in whom shock complicates the pulmonary edema, insertion of a pulmonary-artery catheter is needed to identify the cause of the pulmonary edema and target therapy appropriately.
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